EAP Procedures
Prescribing physicians (investigators) will evaluate patients at Screening, Baseline (Day 0), Day 28, Day 56 and every two months thereafter until the discontinuation of aztreonam lysine for inhalation. The table below outlines the data collected and tasks required at each visit.

Next: Review patient entry criteria